In order to confirm the involvement of Fas and EGFR-Ras signaling pathways in the treatment of hyperoside in human bladder cancer cells, Western blotting was performed to detect the expression levels of Fas, EGFR and Ras, which are upstream proteins in the MAPK and Akt signaling pathways. The gene discussed is EGFR; the disease is urinary bladder cancer.